Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center Clinical Trial for Optimal Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

NCT06257394 is registered in ClinicalTrials.gov with Hyoung Jin Kang as lead sponsor.

NCT NCT06257394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06257394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center Clinical Trial for Optimal Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea
Lead sponsor
Hyoung Jin Kang
Phase
Phase 2
Overall status
Recruiting
Start date
October 20, 2024
Completion date
December 31, 2034
Enrollment
74 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, pediatric